Immumem Therapeutics engages in development of best-in-class scalable and affordable allogeneic iPSC-derived cell therapies using a novel immunological memory platform against lethal cancer types by directly combating their relapse.
This company has no org chart yet
This company has no teams yet
This company has no offices yet